EP3204040
TREATMENT OF CANCER USING TLR9 AGONISTS AND CHECKPOINT INHIBITORS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
9.10.2015EP published:
8.12.2021EP application number:
15848691.0
EPO information:
European Patent Register
Max expiry date:
8.10.2035
Title in English:
TREATMENT OF CANCER USING TLR9 AGONISTS AND CHECKPOINT INHIBITORSLanguage of the patent:
English
Timeline
Today
9.10.2015EP application
8.12.2021EP Publication
Owner
Name:
Idera Pharmaceuticals, Inc.Address:
167 Sidney Street, Cambridge, MA 02319, US
Inventor
Name:
WANG, DaqingAddress:
Bedford, MA 01730, US
Name:
JIANG, WayneAddress:
Waltham, MA 02452, US
Name:
AGRAWAL, SudhirAddress:
Shrewsbury, MA 01545, US
Priority
Number:
201462062274 PDate:
10.10.2014Country:
US
Number:
201562218934 PDate:
15.9.2015Country:
US
Classification
Categories:
A61K 31/7115, A61K 39/00, A61K 39/39, A61K 45/06, A61K 9/00, C07K 14/435, A61N 5/00, A61P 35/00, A61P 35/02, A61P 35/04, A61P 43/00